Exercise and COPD: Therapeutic Responses, Disease-Related Outcomes, and Activity-Promotion Strategies

References

• . World Health Organization. World Health Statistics 2008. http://www.who.int/whosis/whostat/EN_WHS08_Full.pdf. Accessed March 16, 2011
   Google Scholar
• . Jemal A, Ward E, Hao Y, Thun M. Trends in the leading causes of death in the United States, 1970-2002. JAMA. 2005;294(10):1255–1259
   PubMed Web of Science ®Google Scholar
• . Global Initiative for Chronic Obstructive Lung Disease. Global Strategy for the Diagnosis, Management and Prevention of COPD. Revised 2011. http://www.goldcopd.org/uploads/users/files/GOLD_Report_2011Dec30.pdf. Updated December 30, 2011. Accessed January 2, 2012
   Google Scholar
• . Decramer M, Rennard S, Troosters T, . COPD as a lung disease with systemic consequences—clinical impact, mechanisms, and potential for early intervention. COPD. 2008;5(4):235–256
   PubMedGoogle Scholar
• . Finkelstein J, Cha E, Scharf SM. Chronic obstructive pulmonary disease as an independent risk factor for cardiovascular morbidity. Int J Chron Obstruct Pulmon Dis. 2009;4:337–349
   PubMedGoogle Scholar
• . Mannino DM, Braman S. The epidemiology and economics of chronic obstructive pulmonary disease. Proc Am Thorac Soc. 2007;4(7):502–506
   PubMedGoogle Scholar
• . Troosters T, Sciurba F, Battaglia S, . Physical inactivity in patients with COPD, a controlled multi-center pilot-study. Respir Med. 2010;104(7):1005–1011
   PubMed Web of Science ®Google Scholar
• . ZuWallack R. How are you doing? What are you doing? Differing perspectives in the assessment of individuals with COPD. COPD. 2007;4(3):293–297
   PubMedGoogle Scholar
• . McDonough JE, Yuan R, Suzuki M, . Small-airway obstruction and emphysema in chronic obstructive pulmonary disease. N Engl J Med. 2011;365(17):1567–1575
   PubMed Web of Science ®Google Scholar
• . Hogg JC, Timens W. The pathology of chronic obstructive pulmonary disease. Annu Rev Pathol. 2009;4:435–459
   PubMed Web of Science ®Google Scholar
• . Molfino NA. Genetics of COPD. Chest. 2004;125(5):1929–1940
   PubMed Web of Science ®Google Scholar
• . Pepin V, Laviolette L, Saey D, Maltais F. Synergetic interactions between rehabilitation and pharmacotherapy in COPD. Clin Invest Med. 2006;29(3):170–177
   PubMed Web of Science ®Google Scholar
• . Aliverti A, Macklem PT. The major limitation to exercise performance in COPD is inadequate energy supply to the respiratory and locomotor muscles. J Appl Physiol. 2008;105(2):749–751
   PubMed Web of Science ®Google Scholar
• . Debigaré R, Maltais F. Last Word on Point: Counterpoint: The major limitation to exercise performance in COPD is 1) inadequate energy supply to the respiratory and locomotor muscles, 2) lower limb muscle dysfunction, 3) dynamic hyperinflation. J Appl Physiol. 2008;105(2):764
   PubMed Web of Science ®Google Scholar
• . Aliverti A, Macklem PT. Last Word on Point: Counterpoint: The major limitation to exercise performance in COPD is 1) inadequate energy supply to the respiratory and locomotor muscles, 2) lower limb muscle dysfunction, 3) dynamic hyperinflation. J Appl Physiol. 2008;105(2):763
   PubMed Web of Science ®Google Scholar
• . Debigaré R, Maltais F. The major limitation to exercise performance in COPD is lower limb muscle dysfunction. J Appl Physiol. 2008;105(2):751–753
   PubMed Web of Science ®Google Scholar
• . O'Donnell D, Webb K. Last Word on Point: Counterpoint: The major limitation to exercise performance in COPD is 1) inadequate energy supply to the respiratory and locomotor muscles, 2) lower limb muscle dysfunction, 3) dynamic hyperinflation. J Appl Physiol. 2008;105(2):765
   PubMed Web of Science ®Google Scholar
• . Pepin V, Saey D, Laviolette L, Maltais F. Exercise capacity in chronic obstructive pulmonary disease: mechanisms of limitation. COPD. 2007;4(3):195–204
   PubMedGoogle Scholar
• . Katz PP, Gregorich S, Eisner M, . Disability in valued life activities among individuals with COPD and other respiratory conditions. J Cardiopulm Rehabil Prev. 2010;30(2):126–136
   PubMed Web of Science ®Google Scholar
• . Cooper CB. Airflow obstruction and exercise. Respir Med. 2009;103(3):325–334
   PubMed Web of Science ®Google Scholar
• . National Guideline Clearinghouse (NGC-7228). Coronary artery disease (CAD) clinical practice guidelines. Kaiser Permanente Care Management Institute. http://guideline.gov/content.aspx?id=14438. Accessed March 2, 2011
   Google Scholar
• . O'Donnell DE, Revill SM, Webb KA. Dynamic hyperinflation and exercise intolerance in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2001;164(5):770–777
   PubMed Web of Science ®Google Scholar
• . Deesomchok A, Webb KA, Forkert L, . Lung hyperinflation and its reversibility in patients with airway obstruction of varying severity. COPD. 2010;7(6):428–437
   PubMedGoogle Scholar
• . Hannink J, Lahaije A, Bischoff E, . Dynamic hyperinflation after metronome-paced hyperventilation in COPD—a 2 year follow-up. Respir Med. 2010;104(11):1700–1705
   PubMed Web of Science ®Google Scholar
• . Ofir D, Laveneziana P, Webb KA, Lam YM, O'Donnell DE. Mechanisms of dyspnea during cycle exercise in symptomatic patients with GOLD stage I chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2008;177(6):622–629
   PubMed Web of Science ®Google Scholar
• . Saey D, Debigare R, LeBlanc P, . Contractile leg fatigue after cycle exercise: a factor limiting exercise in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2003;168(4):425–430
   PubMed Web of Science ®Google Scholar
• . Jones PW. Health status and the spiral of decline. COPD. 2009;6(1):59–63
   PubMedGoogle Scholar
• . Couillard A, Muir JF, Veale D. COPD recent findings: impact on clinical practice. COPD. 2010;7(3):204–213
   PubMedGoogle Scholar
• . Lewis R, Cramp F. Facilitators and barriers to exercise maintenance in chronic obstructive pulmonary disease: patient views. Physiotherapy Ireland. 2010;31(2)19–24
   Google Scholar
• . Janssens T, De Peuter S, Stans L, . Dyspnea perception in COPD: association between anxiety, dyspnea-related fear and dyspnea in a pulmonary rehabilitation program. Chest. 2011;140(3):618–625
   PubMed Web of Science ®Google Scholar
• . Myers J, Prakash M, Froelicher V, Do D, Partington S, Atwood JE. Exercise capacity and mortality among men referred for exercise testing. N Engl J Med. 2002;346(11):793–801
   PubMed Web of Science ®Google Scholar
• . Oga T, Nishimura K, Tsukino M, Sato S, Hajiro T. Analysis of the factors related to mortality in chronic obstructive pulmonary disease: role of exercise capacity and health status. Am J Respir Crit Care Med. 2003;167(4):544–549
   PubMed Web of Science ®Google Scholar
• . Garcia-Aymerich J, Lange P, Benet M, Schnohr P, Antó JM. Regular physical activity reduces hospital admission and mortality in chronic obstructive pulmonary disease: a population based cohort study. Thorax. 2006;61(9):772–778
   PubMed Web of Science ®Google Scholar
• . Garcia-Aymerich J, Lange P, Benet M, Schnohr P, Antó JM. Regular physical activity modifies smoking-related lung function decline and reduces risk of chronic obstructive pulmonary disease: a population-based cohort study. Am J Respir Crit Care Med. 2007;175(5):458–463
   PubMed Web of Science ®Google Scholar
• . Pelkonen M, Notkola IL, Lakka T, Tukiainen HO, Kivinen P, Nissinen A. Delaying decline in pulmonary function with physical activity: a 25-year follow-up. Am J Respir Crit Care Med. 2003;168(4):494–499
   PubMed Web of Science ®Google Scholar
• . Pitta F, Troosters T, Probst VS, Spruit MA, Decramer M, Gosselink R. Physical activity and hospitalization for exacerbation of COPD. Chest. 2006;129(3):536–544
   PubMed Web of Science ®Google Scholar
• . Celli BR, Cote CG, Marin JM, . The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med. 2004;350(10):1005–1012
   PubMed Web of Science ®Google Scholar
• . Nishimura K, Izumi T, Tsukino M, Oga T. Dyspnea is a better predictor of 5-year survival than airway obstruction in patients with COPD. Chest. 2002;121(5):1434–1440
   PubMed Web of Science ®Google Scholar
• . Waschki B, Kirsten A, Holz O, . Physical activity is the strongest predictor of all-cause mortality in patients with COPD: a prospective cohort study. Chest. 2011;140(2):331–342
   PubMed Web of Science ®Google Scholar
• . Wisløff U, Najjar SM, Ellingsen O, . Cardiovascular risk factors emerge after artificial selection for low aerobic capacity. Science. 2005;307(5708):418–420
   PubMed Web of Science ®Google Scholar
• . Haskell WL. The influence of exercise on the concentrations of triglyceride and cholesterol in human plasma. Exerc Sport Sci Rev. 1984;12:205–244
   PubMedGoogle Scholar
• . Fagard RH. Effects of exercise, diet and their combination on blood pressure. J Hum Hypertens. 2005;19( suppl 3):S20–S24
   PubMed Web of Science ®Google Scholar
• . Ren JM, Semenkovich CF, Gulve EA, Gao J, Holloszy JO. Exercise induces rapid increases in GLUT4 expression, glucose transport capacity, and insulin-stimulated glycogen storage in muscle. J Biol Chem. 1994;269(20):14396–14401
   PubMed Web of Science ®Google Scholar
• . Thorp AA, Owen N, Neuhaus M, Dunstan DW. Sedentary behaviors and subsequent health outcomes in adults: a systematic review of longitudinal studies, 1996-2011. Am J Prev Med. 2011;41(2):207–215
   PubMed Web of Science ®Google Scholar
• . Marquis K, Debigaré R, Lacasse Y, . Midthigh muscle cross-sectional area is a better predictor of mortality than body mass index in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2002;166(6):809–813
   PubMed Web of Science ®Google Scholar
• . Schols AM, Broekhuizen R, Weling-Scheepers CA, Wouters EF. Body composition and mortality in chronic obstructive pulmonary disease. Am J Clin Nutr. 2005;82(1):53–59
   PubMed Web of Science ®Google Scholar
• . Garcia-Aymerich J, Serra I, Gómez FP, . Physical activity and clinical and functional status in COPD. Chest. 2009;136(1):62–70
   PubMed Web of Science ®Google Scholar
• . Seymour JM, Moore L, Jolley CJ, . Outpatient pulmonary rehabilitation following acute exacerbations of COPD. Thorax. 2010;65(5):423–428
   PubMed Web of Science ®Google Scholar
• . Spruit MA, Gosselink R, Troosters T, . Muscle force during an acute exacerbation in hospitalised patients with COPD and its relationship with CXCL8 and IGF-I. Thorax. 2003;58(9):752–756
   PubMed Web of Science ®Google Scholar
• . Troosters T, Probst VS, Crul T, . Resistance training prevents deterioration in quadriceps muscle function during acute exacerbations of chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2010;181(10):1072–1077
   PubMed Web of Science ®Google Scholar
• . McNicholas WT. Impact of sleep in COPD. Chest. 2000;117( 2 suppl): S48–S53
   PubMed Web of Science ®Google Scholar
• . Loprinzi PD, Cardinal BJ. Association between objectively-measured physical activity and sleep, NHANES 2005-2006. Mental Health and Physical Activity. 2011;4(2):65–69
   Google Scholar
• . Myers J, Bader D, Madhavan R, Froelicher V. Validation of a specific activity questionnaire to estimate exercise tolerance in patients referred for exercise testing. Am Heart J. 2001;142(6):1041–1046
   PubMed Web of Science ®Google Scholar
• . Ståhl E, Jansson SA, Jonsson AC, Svensson K, Lundbäck B, Andersson F. Health-related quality of life, utility, and productivity outcomes instruments: ease of completion by subjects with COPD. Health Qual Life Outcomes. 2003;1:18
   PubMedGoogle Scholar
• . Cella D. Functional Assessment of Chronic Illness Therapy (FACIT)-Dyspnea Short Form. http://www.facit.org/FACITOrg/Questionnaires. Accessed January 15, 2013
   Google Scholar
• . Langer D, Gosselink R, Sena R, Burtin C, Decramer M, Troosters T. Validation of two activity monitors in patients with COPD. Thorax. 2009;64(7):641–642
   PubMed Web of Science ®Google Scholar
• . Langer D, Pitta F, Troosters T, Burtin C, Decramer M, Gosselink R. Quantifying physical activity in COPD: different measures for different purposes. Thorax. 2009;64(5):458
   PubMed Web of Science ®Google Scholar
• . Pitta F, Troosters T, Spruit MA, Decramer M, Gosselink R. Activity monitoring for assessment of physical activities in daily life in patients with chronic obstructive pulmonary disease. Arch Phys Med Rehabil. 2005;86(10):1979–1985
   PubMed Web of Science ®Google Scholar
• . Pitta F, Troosters T, Spruit MA, Probst VS, Decramer M, Gosselink R. Characteristics of physical activities in daily life in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2005;171(9):972–977
   PubMed Web of Science ®Google Scholar
• . Cavalheri V, Donária L, Ferreira T, . Energy expenditure during daily activities as measured by two motion sensors in patients with COPD. Respir Med. 2011;105(6):922–929
   PubMed Web of Science ®Google Scholar
• . Bornstein DB, Beets MW, Byun W, . Equating accelerometer estimates of moderate-to-vigorous physical activity: in search of the Rosetta Stone. J Sci Med Sport. 2011;14(5):404–410
   PubMed Web of Science ®Google Scholar
• . Hsia D, Casaburi R, Pradhan A, Torres E, Porszasz J. Physiological responses to linear treadmill and cycle ergometer exercise in COPD. Eur Respir J. 2009;34(3):605–615
   PubMed Web of Science ®Google Scholar
• . O'Donnell DE, Travers J, Webb KA, . Reliability of ventilatory parameters during cycle ergometry in multicentre trials in COPD. Eur Respir J. 2009;34(4):866–874
   PubMed Web of Science ®Google Scholar
• . Oga T, Nishimura K, Tsukino M, Hajiro T, Ikeda A, Izumi T. The effects of oxitropium bromide on exercise performance in patients with stable chronic obstructive pulmonary disease. A comparison of three different exercise tests. Am J Respir Crit Care Med. 2000;161(6):1897–1901
   PubMed Web of Science ®Google Scholar
• . Pepin V, Saey D, Whittom F, LeBlanc P, Maltais F. Walking versus cycling: sensitivity to bronchodilation in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2005;172(12):1517–1522
   PubMed Web of Science ®Google Scholar
• . American Thoracic Society; American College of Chest Physicians. ATS/ACCP Statement on cardiopulmonary exercise testing. Am J Respir Crit Care Med. 2003;167(2):211–277
   PubMed Web of Science ®Google Scholar
• . Kocks JW, Asijee GM, Tsiligianni IG, Kerstjens HA, van der Molen T. Functional status measurement in COPD: a review of available methods and their feasibility in primary care. Prim Care Respir J. 2011;20(3):269–275
   PubMedGoogle Scholar
• . Pepin V, Brodeur J, Lacasse Y, . Six-minute walking versus shuttle walking: responsiveness to bronchodilation in chronic obstructive pulmonary disease. Thorax. 2007;62(4):291–298
   PubMed Web of Science ®Google Scholar
• . Singh SJ, Morgan MD, Scott S, Walters D, Hardman AE. Development of a shuttle walking test of disability in patients with chronic airways obstruction. Thorax. 1992;47(12):1019–1024
   PubMed Web of Science ®Google Scholar
• . Revill SM, Morgan MD, Singh SJ, Williams J, Hardman AE. The endurance shuttle walk: a new field test for the assessment of endurance capacity in chronic obstructive pulmonary disease. Thorax. 1999;54(3):213–222
   PubMed Web of Science ®Google Scholar
• . Cooper CB, Abrazado M, Legg D, Kesten S. Development and implementation of treadmill exercise testing protocols in COPD. Int J Chron Obstruct Pulmon Dis. 2010;5:375–385
   PubMedGoogle Scholar
• . Poulain M, Durand F, Palomba B, . 6-minute walk testing is more sensitive than maximal incremental cycle testing for detecting oxygen desaturation in patients with COPD. Chest. 2003;123(5):1401–1407
   PubMed Web of Science ®Google Scholar
• . O'Donnell DE, Flüge T, Gerken F, . Effects of tiotropium on lung hyperinflation, dyspnoea and exercise tolerance in COPD. Eur Respir J. 2004;23(6):832–840
   PubMed Web of Science ®Google Scholar
• . O'Donnell DE, Voduc N, Fitzpatrick M, Webb KA. Effect of salmeterol on the ventilatory response to exercise in chronic obstructive pulmonary disease. Eur Respir J. 2004;24(1):86–94
   PubMed Web of Science ®Google Scholar
• . Man WD, Soliman MG, Gearing J, . Symptoms and quadriceps fatigability after walking and cycling in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2003;168(5):562–567
   PubMed Web of Science ®Google Scholar
• . Neder JA, Fuld JP, Overend T, . Effects of formoterol on exercise tolerance in severely disabled patients with COPD. Respir Med. 2007;101(10):2056–2064
   PubMed Web of Science ®Google Scholar
• . Worth H, Förster K, Eriksson G, Nihlén U, Peterson S, Magnussen H. Budesonide added to formoterol contributes to improved exercise tolerance in patients with COPD. Respir Med. 2010;104(10):1450–1459
   PubMed Web of Science ®Google Scholar
• . Okudan N, Gök M, Gökbel H, Süerdem M. Single dose of tiotropium improves the 6-minute walk distance in chronic obstructive pulmonary disease. Lung. 2006;184(4):201–204
   PubMed Web of Science ®Google Scholar
• . Grove A, Lipworth BJ, Reid P, . Effects of regular salmeterol on lung function and exercise capacity in patients with chronic obstructive airways disease. Thorax. 1996;51(7):689–693
   PubMed Web of Science ®Google Scholar
• . Puhan MA, Mador MJ, Held U, Goldstein R, Guyatt GH, Schünemann HJ. Interpretation of treatment changes in 6-minute walk distance in patients with COPD. Eur Respir J. 2008;32(3):637–643
   PubMed Web of Science ®Google Scholar
• . Verkindre C, Bart F, Aguilaniu B, . The effect of tiotropium on hyperinflation and exercise capacity in chronic obstructive pulmonary disease. Respiration. 2006;73(4):420–427
   PubMed Web of Science ®Google Scholar
• . Bédard ME, Brouillard C, Pepin V, . Tiotropium improves walking endurance in COPD. Eur Respir J. 2012;39(2):265–271
   PubMed Web of Science ®Google Scholar
• . Brouillard C, Pepin V, Milot J, Lacasse Y, Maltais F. Endurance shuttle walking test: responsiveness to salmeterol in COPD. Eur Respir J. 2008;31(3):579–584
   PubMed Web of Science ®Google Scholar
• . Pepin V, Laviolette L, Brouillard C, . Significance of changes in endurance shuttle walking performance. Thorax. 2011;66(2):115–120
   PubMed Web of Science ®Google Scholar
• . Casaburi R, Kukafka D, Cooper CB, Witek TJ Jr, Kesten S. Improvement in exercise tolerance with the combination of tiotropium and pulmonary rehabilitation in patients with COPD. Chest. 2005;127(3):809–817
   PubMed Web of Science ®Google Scholar
• . Berton DC, Reis M, Siqueira AC, . Effects of tiotropium and formoterol on dynamic hyperinflation and exercise endurance in COPD. Respir Med. 2010;104(9):1288–1296
   PubMed Web of Science ®Google Scholar
• . Saey D, Pepin V, Brodeur J, . Use of facemask and mouthpiece to assess constant-workrate exercise capacity in COPD. Med Sci Sports Exerc. 2006;38(2):223–230
   PubMed Web of Science ®Google Scholar
• . Whipp BJ, Ward SA. Quantifying intervention-related improvements in exercise tolerance. Eur Respir J. 2009;33(6):1254–1260
   PubMed Web of Science ®Google Scholar
• . Maltais F, Hamilton A, Marciniuk D, . Improvements in symptom-limited exercise performance over 8 h with once-daily tiotropium in patients with COPD. Chest. 2005;128(3):1168–1178
   PubMed Web of Science ®Google Scholar
• . O'Donnell DE, Sciurba F, Celli B, . Effect of fluticasone propionate/salmeterol on lung hyperinflation and exercise endurance in COPD. Chest. 2006;130(3):647–656
   PubMed Web of Science ®Google Scholar
• . Maltais F, Celli B, Casaburi R, . Aclidinium bromide improves exercise endurance and lung hyperinflation in patients with moderate to severe COPD. Respir Med. 2011;105(4):580–587
   PubMed Web of Science ®Google Scholar
• . Mador MJ, Bozkanat E, Aggarwal A, Shaffer M, Kufel TJ. Endurance and strength training in patients with COPD. Chest. 2004;125(6):2036–2045
   PubMed Web of Science ®Google Scholar
• . Porszasz J, Casaburi R, Somfay A, Woodhouse LJ, Whipp BJ. A treadmill ramp protocol using simultaneous changes in speed and grade. Med Sci Sports Exerc. 2003;35(9):1596–1603
   PubMed Web of Science ®Google Scholar
• . O'Donnell DE, Casaburi R, Vincken W, . Effect of indacaterol on exercise endurance and lung hyperinflation in COPD. Respir Med. 2011;105(7):1030–1036
   PubMed Web of Science ®Google Scholar
• . Casaburi R. Factors determining constant work rate exercise tolerance in COPD and their role in dictating the minimal clinically important difference in response to interventions. COPD. 2005;2(1):131–136
   PubMedGoogle Scholar
• . Laviolette L, Bourbeau J, Bernard S, . Assessing the impact of pulmonary rehabilitation on functional status in COPD. Thorax. 2008;63(2):115–121
   PubMed Web of Science ®Google Scholar
• . Zhang X, Waterman LA, Ward J, Baird JC, Mahler DA. Advantages of endurance treadmill walking compared with cycling to assess bronchodilator therapy. Chest. 2010;137(6):1354–1361
   PubMed Web of Science ®Google Scholar
• . Deschênes D, Pepin V, Saey D, LeBlanc P, Maltais F. Locus of symptom limitation and exercise response to bronchodilation in chronic obstructive pulmonary disease. J Cardiopulm Rehabil Prev. 2008;28(3):208–214
   PubMed Web of Science ®Google Scholar
• . Hay JG, Stone P, Carter J, . Bronchodilator reversibility, exercise performance and breathlessness in stable chronic obstructive pulmonary disease. Eur Respir J. 1992;5(6):659–664
   PubMed Web of Science ®Google Scholar
• . Spence DP, Hay JG, Carter J, Pearson MG, Calverley PM. Oxygen desaturation and breathlessness during corridor walking in chronic obstructive pulmonary disease: effect of oxitropium bromide. Thorax. 1993;48(11):1145–1150
   PubMed Web of Science ®Google Scholar
• . Boyd G, Morice AH, Pounsford JC, Siebert M, Peslis N, Crawford C. An evaluation of salmeterol in the treatment of chronic obstructive pulmonary disease (COPD). Eur Respir J. 1997;10(4):815–821
   PubMed Web of Science ®Google Scholar
• . Mahler DA, Donohue JF, Barbee RA, . Efficacy of salmeterol xinafoate in the treatment of COPD. Chest. 1999;115(4):957–965
   PubMed Web of Science ®Google Scholar
• . O'Donnell D, Maltais F, Porszasz J, . Lung function and exercise impairment in patients with GOLD stage I and II COPD. Poster presented at: American Thoracic Society 108th International Conference; May 18-23, 2012; San Francisco, CA
   Google Scholar
• . Blonshine S, Cao R, Casaburi R, Paden H, Porszasz J. Results from a multi-center cardiopulmonary exercise physiological quality control protocol. Poster presented at: American Thoracic Society 108th International Conference; May 18-23, 2012; San Francisco, CA
   Google Scholar
• . Lacasse Y, Goldstein R, Lasserson TJ, Martin S. Pulmonary rehabilitation for chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2006;(4):CD003793
   Google Scholar
• . Ortega F, Toral J, Cejudo P, . Comparison of effects of strength and endurance training in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2002;166(5):669–674
   PubMed Web of Science ®Google Scholar
• . Porszasz J, Emtner M, Goto S, Somfay A, Whipp BJ, Casaburi R. Exercise training decreases ventilatory requirements and exercise-induced hyperinflation at submaximal intensities in patients with COPD. Chest. 2005;128(4):2025–2034
   PubMed Web of Science ®Google Scholar
• . Pasqua F, Biscione G, Crigna G, Auciello L, Cazzola M. Combining triple therapy and pulmonary rehabilitation in patients with advanced COPD: a pilot study. Respir Med. 2010;104(3):412–417
   PubMed Web of Science ®Google Scholar
• . Crul T, Spruit MA, Gayan-Ramirez G, . Markers of inflammation and disuse in vastus lateralis of chronic obstructive pulmonary disease patients. Eur J Clin Invest. 2007;37(11):897–904
   PubMed Web of Science ®Google Scholar
• . Donaldson GC, Wilkinson TM, Hurst JR, Perera WR, Wedzicha JA. Exacerbations and time spent outdoors in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2005;171(5):446–452
   PubMed Web of Science ®Google Scholar
• . Tashkin DP, Celli B, Senn S, ; UPLIFT Study Investigators.A 4-year trial of tiotropium in chronic obstructive pulmonary disease. N Engl J Med. 2008;359(15):1543–1554
   PubMed Web of Science ®Google Scholar
• . Calverley PM, Anderson JA, Celli B, ; TORCH investigators.Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease. N Engl J Med. 2007;356(8):775–789
   PubMed Web of Science ®Google Scholar
• . Pitta F, Troosters T, Probst VS, Langer D, Decramer M, Gosselink R. Are patients with COPD more active after pulmonary rehabilitation? Chest. 2008;134(2):273–280
   PubMed Web of Science ®Google Scholar
• . Marciniuk DD, Brooks D, Butcher S, et al; Canadian Thoracic Society COPD Committee Expert Working Group. Optimizing pulmonary rehabilitation in chronic obstructive pulmonary disease—practical issues: a Canadian Thoracic Society Clinical Practice Guideline. Can Respir J. 2010;17(4):159–168
   PubMed Web of Science ®Google Scholar
• . Behnke M, Wewel AR, Kirsten D, Jörres RA, Magnussen H. Exercise training raises daily activity stronger than predicted from exercise capacity in patients with COPD. Respir Med. 2005;99(6):711–717
   PubMed Web of Science ®Google Scholar
• . Kesten S, Casaburi R, Kukafka D, Cooper CB. Improvement in self-reported exercise participation with the combination of tiotropium and rehabilitative exercise training in COPD patients. Int J Chron Obstruct Pulmon Dis. 2008;3(1):127–136
   PubMedGoogle Scholar
• . Soicher JE, Mayo NE, Gauvin L, . Trajectories of endurance activity following pulmonary rehabilitation in COPD patients. Eur Respir J. 2012;39(2):272–278
   PubMed Web of Science ®Google Scholar
• . US Department of Health and Human Services. 2008 Physical Activity Guidelines for Americans. http://health.gov/paguidelines/pdf/paguide.pdf. Published August 21, 2009. Accessed March 23, 2012
   Google Scholar
• . Nelson ME, Rejeski WJ, Blair SN, . Physical activity and public health in older adults: recommendation from the American College of Sports Medicine and the American Heart Association. Circulation. 2007;116(9):1094–1105
   PubMed Web of Science ®Google Scholar
• . McGuire KA, Ross R. Incidental physical activity is positively associated with cardiorespiratory fitness. Med Sci Sports Exerc. 2011;43(11):2189–2194
   PubMed Web of Science ®Google Scholar
• . Gordon NF, Kohl HW, Blair SN. Life Style Exercise: A new strategy to promote physical activity for adults. J Cardiopulm Rehabil. 1993;13(3):161–163
   Google Scholar
• . Pinto BM, Goldstein MG, Marcus BH. Activity counseling by primary care physicians. Prev Med. 1998;27(4):506–513
   PubMed Web of Science ®Google Scholar
• . Lewis BS, Lynch WD. The effect of physician advice on exercise behavior. Prev Med. 1993;22(1):110–121
   PubMed Web of Science ®Google Scholar
• . Cardinal BJ, Kosma M. Self-efficacy and the stages and processes of change associated with adopting and maintaining muscular fitness-promoting behaviors. Res Q Exerc Sport. 2004;75(2):186–196
   PubMed Web of Science ®Google Scholar
• . Miller WR, Rollnick S, eds. Motivational Interviewing: Preparing People for Change. 2nd ed. New York, NY: Guilford Press; 2002
   Google Scholar
• . Puhan MA, Chandra D, Mosenifar Z, ; and National Emphysema Treatment Trial (NETT) Research Group.The minimal important difference of exercise tests in severe COPD. Eur Respir J. 2011;37(4):784–790
   PubMed Web of Science ®Google Scholar